Calamos Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-21,475
Closed -$884K 1226
2021
Q4
$884K Buy
+21,475
New +$949K ﹤0.01% 1021
2021
Q2
Sell
-56,000
Closed -$3.01M 1011
2021
Q1
$3.01M Buy
56,000
+4,419
+9% +$255K 0.02% 633
2020
Q4
$2.52M Sell
51,581
-1,085
-2% -$50.3K 0.01% 612
2020
Q3
$1.71M Buy
+52,666
New +$1.67M 0.01% 610
2020
Q1
Sell
-25,270
Closed -$705K 805
2019
Q4
$705K Sell
25,270
-110,750
-81% -$2.87M ﹤0.01% 688
2019
Q3
$3.26M Sell
136,020
-61,899
-31% -$1.65M 0.02% 573
2019
Q2
$5.64M Buy
+197,919
New +$4.94M 0.03% 490

Other funds holding VCYT

Calamos Advisors's VCYT Position: Q1 2022 in Review

Calamos Advisors sold out of Veracyte (VCYT) in Q1 2022, closing a stake of 21,475 shares — an estimated $884K sold.

Calamos Advisors first reported a position in VCYT in Q2 2019 and held it in 7 quarters. The position peaked at $5.64M in Q2 2019. 205 funds tracked by Wall St. Rank hold VCYT as of Q1 2022.

  • Calamos Advisors reported no remaining Veracyte position as of Q1 2022 after selling out during the quarter.
  • Calamos Advisors sold 21,475 Veracyte shares in Q1 2022, an estimated $884K.
  • Calamos Advisors first reported a position in Veracyte in Q2 2019 and held it in 7 quarters.
  • Calamos Advisors's Veracyte position peaked at $5.64M in Q2 2019.
  • 205 funds tracked by Wall St. Rank held Veracyte as of Q1 2022.

Based on Calamos Advisors's 13F filing for Q1 2022, filed 3 May 2022.